AHCO

AdaptHealth Corp. (AHCO) 10Y Growth Potential Analysis (2026)

Invetso Score: 3.2/10 — Weak · Last Updated: 2026-08-01

Overall Score

Growth Durability

Revenue base is sizable but the business is not yet translating into durable earnings growth, with TTM net margin at -7.6% and operating margin at -0.3%.

Asset efficiency remains mediocre, with ROA at -5.3% and ROIC near breakeven at -0.2%.

Profitability

Gross margin is only 10.4%, leaving limited room to absorb operating costs.

Interest coverage is negative at -0.09x and pretax margin is -8.2%, indicating the capital structure is still pressuring earnings.

Financial Strength

Liquidity is adequate but not strong, with a current ratio of 1.12x and quick ratio of 0.98x.

Leverage remains elevated, with net debt to EBITDA at 7.0x and debt to capital at 60.0%.

Valuation

The stock screens cheaply on sales and book value, with EV/sales at 0.93x and price/book at 0.57x.

However, the low multiples are offset by negative earnings and weak cash conversion, so valuation is only moderately attractive.

Cash Flow Quality

Operating cash flow is positive, but free cash flow conversion is weak, with FCF/OCF at 16.7%.

Capex remains heavy relative to operating cash flow at 83.3%, limiting true discretionary cash generation.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on AdaptHealth Corp.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →